D-Lin-MC3-DMA

D-Lin-MC3-DMA

D-Lin-MC3-DMA (MC3) is a potent synthetic ionizable lipid. Its full name is (6Z,9Z,28Z,31Z)-Heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate. D-Lin-MC3-DMA has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs) for the delivery of siRNA, mRNA, DNA. The pKa is 6.44. Reagent grade, for research purpose.

Molecular structure of the compound BP-25497
    • Unit
    • Price
    • Qty
    • 100 MG
    • $320.00
    • 250 MG
    • $560.00
    • 500 MG
    • $780.00
    • 1 G
    • $1200.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire

Product Citations

  1. Akanchise, T.; Luo, F.; Angelov, B.; Deng, Y.; Angelova, A. Designed Liquid Crystalline Nanoassemblies from Clinically Validated Polyunsaturated Lipids for Combined Antioxidant, Anti‐Apoptotic, and Neurotrophic Treatments. Advanced Healthcare Materials 2026.
    https://doi.org/10.1002/adhm.202505595
  2. Borah, A., Giacobbo, V., Binici, B., Baillie, R., & Perrie, Y. (2025). From in vitro to in Vivo: The Dominant role of PEG-Lipids in LNP performance. European Journal of Pharmaceutics and Biopharmaceutics, 114726.
    https://doi.org/10.1016/j.ejpb.2025.114726
  3. Borah, A., Giacobbo, V., Binici, B., Baillie, R., & Perrie, Y. (2025). From in vitro to in vivo: The Dominant role of PEG-Lipids in LNP performance. European Journal of Pharmaceutics and Biopharmaceutics, 114726.
    https://www.sciencedirect.com/science/article/pii/S0939641125001031
  4. Chiesa, E., Caimi, A., Bellotti, M., Giglio, A., Conti, B., Dorati, R., ... & Genta, I. (2024). Effect of Micromixer Design on Lipid Nanocarriers Manufacturing for the Delivery of Proteins and Nucleic Acids. Pharmaceutics, 16(4), 507.
    https://www.mdpi.com/1999-4923/16/4/507
  5. Choi, M., Jung, O., Lee, E., & Choi, J. S. (2024). Study of functional lipid nanoparticles for mRNA delivery using new ionizable tocopherol derivatives. Bulletin of the Korean Chemical Society, 45(11), 929-936.
    https://onlinelibrary.wiley.com/doi/abs/10.1002/bkcs.12909
  6. Coussens, E. Exploring the potential of CRISPR/Cas9 lipid nanoparticles to cure HIV.
    https://lib.ugent.be/catalog/rug01:003212736
  7. Evdokimou, M.; Alaqabani, H.; Hussain, M.; Perrie, Y. Incorporating Immunostimulatory Lipids Into Lipid Nanoparticles: Exploring Expression and Immune Responses. European Journal of Pharmaceutics and Biopharmaceutics 2026, 223, 115034.
    https://doi.org/10.1016/j.ejpb.2026.115034
  8. Felgner, J., Hernandez-Davies, J. E., Strahsburger, E., Silzel, E., Nakajima, R., Jain, A., ... & Liang, L. (2025). Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2. npj Vaccines, 10(1), 123.
    https://www.nature.com/articles/s41541-025-01153-6
  9. Felgner, J., Hernandez-Davies, J.E., Strahsburger, E. et al. Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2. npj Vaccines 10, 123 (2025)
    https://doi.org/10.1038/s41541-025-01153-6
  10. Forrester, J., Davidson, C. G., Blair, M., Donlon, L., McLoughlin, D. M., Obiora, C. R., ... & Perrie, Y. (2025). Low-cost microfluidic mixers: are they up to the task?. Pharmaceutics, 17(5), 566.
    https://www.mdpi.com/1999-4923/17/5/566
  11. Forrester, J., Davidson, C. G., Blair, M., Donlon, L., McLoughlin, D. M., Obiora, C. R., ... & Perrie, Y. (2025). Low-cost microfluidic mixers: are they up to the task?. Pharmaceutics, 17(5), 566.
    https://www.mdpi.com/1999-4923/17/5/566
  12. Giacobbo, V. (2025). End-to-end optimization of lipid nanoparticle manufacturing for mRNA delivery.
    https://stax.strath.ac.uk/concern/theses/vx021f609
  13. Giménez-Warren, J., Peña, Á., Heredero, J., Mata, E., Blandín, B., de Miguel, D., ... & Martínez-Oliván, J. (2024). STAAR Lipids: A Novel Ionizable Lipid Synthetic Platform for Efficient mRNA Delivery In Vivo with Tunable Lung Targeting.
    https://doi.org/10.21203/rs.3.rs-5124244/v1
  14. Han, X., Petrova, V., Song, Y., Cheng, Y. T., Jiang, X., Zhou, H., ... & Shi, J. (2025). Lipid nanoparticle delivery of siRNA to dorsal root ganglion neurons to treat pain. bioRxiv, 2025-01.
    https://www.biorxiv.org/content/10.1101/2025.01.23.633455v1.full
  15. Heredero, J., Peña, Á., Broset, E., Blandín, B., de Miguel, D., Alejo, T., Toro, A., Mata, E., López-Gavín, A., Gallego-Lleyda, A., Casabona, D., Lampaya, V., Larraga, A., Pérez-Herrán, E., Luna, D., Orera, I., Romanos, E., García, A., Martínez-Oliván, J., & Giménez-Warren, J. (2025). Predictive Lung- and Spleen-Targeted mRNA Delivery with Biodegradable Ionizable Lipids in Four-Component LNPs. Pharmaceutics, 17(4), 459
    https://www.mdpi.com/1999-4923/17/4/459
  16. Hossainy, S., Kang, S., Gómez Medellín, J. E., Alpar, A. T., Refvik, K. C., Ma, Y. Y., ... & Hubbell, J. A. (2025). Thermoreversibly assembled polymersomes for highly efficient loading, processing and delivery of protein and siRNA biologics. Nature Biomedical Engineering, 1-18.
    https://www.nature.com/articles/s41551-025-01469-7
  17. Jeffrey A. Hubbell, Seounghun KANG, Samir HOSSAINY, Stuart ROWAN, Jorge Emiliano GOMEZ MEDELLIN, Anna J. SLEZAK, Aaron ALPAR. Amphiphilic block copolymers, polymersomes, and methods of use. (WO2025145010A1)
    https://patents.google.com/patent/WO2025145010A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=4
  18. Jeffrey A. Hubbell, Seounghun KANG, Samir HOSSAINY, Stuart ROWAN, Jorge Emiliano GOMEZ MEDELLIN, Anna J. SLEZAK, Aaron ALPAR. Amphiphilic block copolymers, polymersomes, and methods of use. (WO2025145010A1)
    https://patents.google.com/patent/WO2025145010A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=4
  19. Ko, K. H., Lee, S. H., Choi, Y. H., Kang, S. M., Yang, H. S., Lee, S. M., ... & Cha, S. B. (2025). Lipid nanoparticle encapsulated TLR3 agonist adjuvant elicits potent T cell immunity against cancer and viruses. npj Vaccines.
    https://www.nature.com/articles/s41541-025-01349-w
  20. Kuzucu, E. Ü., Schittny, V., Huwyler, J., & Schwarz, M. A. (2025). Capillary‐Based Physicochemical Characterization of Lipid Nanoparticles. Electrophoresis.
    https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/full/10.1002/elps.70032
  21. Lim, H.; Jung, H.; Jeon, H.-G.; Heo, S.; Lee, S.; Lee, E.; Choi, J. S.; Kim, Y.; Yang, J. Impact of Clinically Approved Ionizable Lipids on the Immunogenic Response of Varicella Zoster Virus Glycoprotein E MRNA-LNP Vaccines. 2026.
    https://doi.org/10.2139/ssrn.6056385
  22. Lindsay, S., Hussain, M., Binici, B., & Perrie, Y. (2025). Exploring the challenges of lipid nanoparticle development: the in vitro–in vivo correlation gap. Vaccines, 13(4), 339.
    https://www.mdpi.com/2076-393X/13/4/339
  23. Ogawa, K., Tagami, T., Miyake, S., & Ozeki, T. (2025). Choice of organic solvent affects function of mRNA-LNP; pyridine produces highly functional mRNA-LNP. International Journal of Pharmaceutics, 673, 125367.
    https://doi.org/10.1016/j.ijpharm.2025.125367
  24. Omo-Lamai, S., Wang, Y., Patel, M. N., Essien, E. O., Shen, M., Majumder, A., ... & Brenner, J. S. (2024). Lipid Nanoparticle-Associated Inflammation is Triggered by Sensing of Endosomal Damage: Engineering Endosomal Escape without Side Effects. bioRxiv, 2024-04.
    https://doi.org/10.1101/2024.04.16.589801
  25. Panja, S., Zaman, L. A., Zhang, C., Patel, M., Gorantla, S., Dash, P. K., & Gendelman, H. E. Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV-1 Proviral DNA Excision. Available at SSRN 5136145.
    https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5136145
  26. Patel, N., Avery, E., Huang, Y., & Chung, E. J. (2025). Developing Therapeutically Enhanced Extracellular Vesicles for Atherosclerosis Therapy. Advanced Healthcare Materials, 2404398.
    https://advanced.onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202404398
  27. Peña, Á.; Broset, E.; Lucia, E.; García-Latorre, L.; Navarro, V.; Matute, C.; Gallego-Lleyda, A.; Alejo, T.; Romanos, E.; García, A.; Martínez-Oliván, J.; Giménez-Warren, J. Thioester-Containing Ionizable Lipids with Enhanced Endosomal Escape and Biodegradability for MRNA and TRNA Delivery. Pharmaceutics 2026, 18 (4), 472.
    https://doi.org/10.3390/pharmaceutics18040472
  28. Sahel, D. K., Renner, J., Vlasova, K. Y., Pennock, N. D., Haque, S. T., Jozic, A., ... & Sahay, G. (2026). Improved localized mRNA delivery using lipid nanoparticles with a novel synthetic cholesterol derivative. RSC pharmaceutics.
    https://pubs.rsc.org/en/content/articlehtml/2026/pm/d5pm00166h
  29. Sakers, S. H., Fiduccia, G., Byrne, K. E., Reddy, B. P. K., Dahlman, J. E., & Prausnitz, M. R. (2025). The effect of mRNA-lipid nanoparticle composition on stability during microneedle patch manufacturing. European Journal of Pharmaceutics and Biopharmaceutics, 114819.
    https://www.sciencedirect.com/science/article/pii/S0939641125001961
  30. Sevarika, B.; Couvidou, A.; Aldawod, D.; Dinamarca, M. C.; McNeil, S. Charge-Driven Lipid Nanoparticle Encapsulation of Enzymes for Enhanced ERT with Reduced Immunogenicity. Journal of Controlled Release 2026, 394, 114859.
    https://doi.org/10.1016/j.jconrel.2026.114859
  31. Shah, S., Ranasinghe, M., Decker, J., Fraser, K., Friedman, A., Wang, Y., ... & Yao, S. (2025). Lipid Nanoparticles with Aptamers Enable Targeted mRNA Delivery to CD4⁺ T Cells. bioRxiv, 2025-09.
    https://www.biorxiv.org/content/10.1101/2025.09.10.675359v1.full
  32. Shi, P., Liu, H., Refaat, A., Nguyen, H., Nguyen, A., Miao, K., ... & Wang, X. (2025). Innovative γ-Oryzanol and KC2 Based Lipid Nanoparticles: OryKL Platform Provides Safe and Efficient In Vivo mRNA Delivery.
    https://chemrxiv.org/engage/chemrxiv/article-details/68bfb8ed728bf9025e262993
  33. Warminski, M., Depaix, A., Ziemkiewicz, K., Spiewla, T., Zuberek, J., Drazkowska, K., ... & Jemielity, J. (2024). Trinucleotide cap analogs with triphosphate chain modifications: synthesis, properties, and evaluation as mRNA capping reagents. Nucleic Acids Research, gkae763.
    https://academic.oup.com/nar/advance-article/doi/10.1093/nar/gkae763/7753433
  34. Wei, Y.; Bailey, C.; Zhang, P.; Herazo-Maya, J.; Karampitsakos, T.; Pescrille, J.; Diaz-Mendez, F.; Lee, D.; Samokhin, A.; Liu, Y.; Drake, W.; Wang, Y. Myeloid HIF-1α Sustains Hypoxic Fibrotic Fronts and Drives Pulmonary Fibrosis. 2026.
    https://doi.org/10.64898/2026.03.09.710578
  35. Zahedipour, F.; Sadeghianfard, S.; Wisser, S.; Dinarvand, M.; Steiner, D.; Ramesh, A.; Trosien, P.; Leibold, J.; Mezger, M.; Mohammadian Gol, T. Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells. Biomedicines 2026, 14 (10), 2365.
    https://doi.org/10.3390/biomedicines14102365
  36. Zhang, J.; Hołubowicz, R.; Smidak, R.; Hu, Y.; Du, S. W.; Felgner, J. H.; Palczewska, G.; Rodrigues Menezes, C.; Risaliti, E.; Dong, Z.; Ma, X.; Shayegan, M. H.; Chen, P. Z.; Xing, L.; Hołubowicz, M.; Li, B.; Liu, D. R.; Felgner, P. L.; Tochtrop, G. P.; Palczewski, K. A Combinatorial Synthetic Strategy for Developing Genome-Editing Protein-Delivery Agents Targeting Mouse Retina. Nature Communications 2026, 17 (1).
    https://doi.org/10.1038/s41467-026-69077-w
  37. 昂輝 小川, 辰秋 田上, 哲也 尾関, 慧 三宅. Nucleic acid-encapsulating lipid nanoparticle production method. (WO2025164564A1)
    https://patents.google.com/patent/WO2025164564A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=3
  38. 김윤경, 전해근, 정혜연, 호베트그응, 이지윤. Lipid compound and composition for delivery of active substance. (WO2024106781A1)
    https://patents.google.com/patent/WO2024106781A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=18